Please enable JavaScript to continue using this application.

Compare $AZTA vs $MRVI | Chartloom

Compare

$AZTA vs $MRVI

Azenta Inc · Maravai LifeSciences Holdings Inc

AZTA

Azenta Inc

MRVI

Maravai LifeSciences Holdings Inc

Compare $AZTA vs $MRVI

Comparing Azenta Inc and Maravai LifeSciences Holdings Inc

AZTAAzenta Inc

MRVIMaravai LifeSciences Holdings Inc

AZTAAzenta Inc

Market cap

$1.74B

P/E (TTM)

—

Forward P/E (NTM)

66.47x

Forward P/S (NTM)

2.69x

Rev growth (TTM)

1.4%

YTD performance

13.0%

52W performance

17.0%

FCF yield

0.6%

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTA

MRVI

Detailed metrics comparison

AZTA

Azenta Inc

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

AZTA$1.74B

MRVI$1.92B

Enterprise Value

AZTA$1.55B

MRVI$2.03B

Price

AZTA$37.72

MRVI$7.44

P/E Ratio

AZTAN/A

MRVIN/A

P/S Ratio

AZTA2.83x

MRVI9.20x

EV/Sales

AZTA2.52x

MRVI9.71x

EV/EBITDA

AZTA37.55x

MRVI24.69x

P/B Ratio

AZTA1.12x

MRVI10.03x

P/FCF Ratio

AZTA175.95x

MRVIN/A

EV/FCF

AZTA156.75x

MRVI-57.75x

PEG Ratio

AZTAN/A

MRVIN/A

Forward P/E (NTM)

AZTA66.47x

MRVIN/A

Forward P/S (NTM)

AZTA2.69x

MRVI8.68x

Revenue (TTM)

AZTA$614M

MRVI$209M

Revenue Growth (YoY)

AZTA1.4%

MRVI-3.3%

Forward Rev Growth

AZTA5.4%

MRVI6.5%

Gross Margin (TTM)

AZTA43.4%

MRVI34.9%

Operating Margin (TTM)

AZTA0.0%

MRVI0.0%

EBITDA Margin (TTM)

AZTA5.3%

MRVI-10.4%

Net Margin (TTM)

AZTA-20.0%

MRVI-37.1%

FCF Margin (TTM)

AZTA1.6%

MRVI-16.8%

Net Income (TTM)

AZTA$-123M

MRVI$-77M

FCF (TTM)

AZTA$10M

MRVI$-35M

EPS (TTM)

AZTA-$2.71

MRVI-$0.52

ROE (TTM)

AZTA-756.0%

MRVI-3542.0%

ROA (TTM)

AZTA-621.0%

MRVI-1054.0%

ROIC (TTM)

AZTA-756.0%

MRVI-1572.0%

Cash

AZTA$190M

MRVI$70M

Debt

AZTA$0

MRVI$177M

Net Cash/Debt

AZTA$190M

MRVI$-107M

Current Ratio (TTM)

AZTA2.50x

MRVI4.05x

Quick Ratio (TTM)

AZTA2.12x

MRVI2.63x

Debt/Equity (TTM)

AZTA0.00x

MRVI0.86x

Debt/Assets (TTM)

AZTA0.0%

MRVI0.0%

Interest Coverage (TTM)

AZTAN/A

MRVIN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

MRVI0.00x

Beta

AZTA1.51

MRVI0.63

52W Performance

AZTA17.0%

MRVI123.4%

YTD Performance

AZTA13.0%

MRVI118.8%

% from 52W High

AZTA-18.7%

MRVI-21.0%

% from 52W Low

AZTA136.8%

MRVI192.3%

Asset Turnover (TTM)

AZTA0.31x

MRVI0.28x

FCF Yield (TTM)

AZTA0.6%

MRVI-1.8%

Earnings Yield (TTM)

AZTA-7.1%

MRVI-4.0%

Dividend Yield (TTM)

AZTAN/A

MRVIN/A

Rule of 40

AZTA3.0

MRVI-20.1

EV/GP/RG

AZTA0.83

MRVI4.63

Ticker research

View AZTA research View MRVI research

Metric	AZTA Azenta Inc	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$1.74B	$1.92B
Enterprise Value	$1.55B	$2.03B
Price	$37.72	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	9.20x
EV/Sales	2.52x	9.71x
EV/EBITDA	37.55x	24.69x
P/B Ratio	1.12x	10.03x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	8.68x
Revenue & Growth
Revenue (TTM)	$614M	$209M
Revenue Growth (YoY)	1.4%	-3.3%
Forward Rev Growth	5.4%	6.5%
Profitability
Gross Margin (TTM)	43.4%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-10.4%
Net Margin (TTM)	-20.0%	-37.1%
FCF Margin (TTM)	1.6%	-16.8%
Net Income (TTM)	$-123M	$-77M
FCF (TTM)	$10M	$-35M
EPS (TTM)	-$2.71	-$0.52
ROE (TTM)	-756.0%	-3542.0%
ROA (TTM)	-621.0%	-1054.0%
ROIC (TTM)	-756.0%	-1572.0%
Financial Health
Cash	$190M	$70M
Debt	$0	$177M
Net Cash/Debt	$190M	$-107M
Current Ratio (TTM)	2.50x	4.05x
Quick Ratio (TTM)	2.12x	2.63x
Debt/Equity (TTM)	0.00x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.63
52W Performance	17.0%	123.4%
YTD Performance	13.0%	118.8%
% from 52W High	-18.7%	-21.0%
% from 52W Low	136.8%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.28x
FCF Yield (TTM)	0.6%	-1.8%
Earnings Yield (TTM)	-7.1%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-20.1
EV/GP/RG	0.83	4.63
Ticker research	View AZTA research	View MRVI research

Valuation

P/S Ratio

AZTA

2.83x

MRVI

9.20x

EV/FCF

MRVI

-57.75x

AZTA

156.75x

Growth & revenue

Revenue Growth TTM

AZTA

1.4%

MRVI

-3.3%

Forward Revenue Growth

MRVI

6.5%

AZTA

5.4%

Profitability & performance

Gross Margin

AZTA

43.4%

MRVI

34.9%

ROE

AZTA

-756.0%

MRVI

-3542.0%

FCF Yield %

AZTA

0.6%

MRVI

-1.8%

52-Week Performance

MRVI

123.4%

AZTA

17.0%

Detailed metrics comparison

AZTA

Azenta Inc

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

AZTA$1.74B

MRVI$1.92B

Enterprise Value

AZTA$1.55B

MRVI$2.03B

Price

AZTA$37.72

MRVI$7.44

P/E Ratio

AZTAN/A

MRVIN/A

P/S Ratio

AZTA2.83x

MRVI9.20x

EV/Sales

AZTA2.52x

MRVI9.71x

EV/EBITDA

AZTA37.55x

MRVI24.69x

P/B Ratio

AZTA1.12x

MRVI10.03x

P/FCF Ratio

AZTA175.95x

MRVIN/A

EV/FCF

AZTA156.75x

MRVI-57.75x

PEG Ratio

AZTAN/A

MRVIN/A

Forward P/E (NTM)

AZTA66.47x

MRVIN/A

Forward P/S (NTM)

AZTA2.69x

MRVI8.68x

Revenue (TTM)

AZTA$614M

MRVI$209M

Revenue Growth (YoY)

AZTA1.4%

MRVI-3.3%

Forward Rev Growth

AZTA5.4%

MRVI6.5%

Gross Margin (TTM)

AZTA43.4%

MRVI34.9%

Operating Margin (TTM)

AZTA0.0%

MRVI0.0%

EBITDA Margin (TTM)

AZTA5.3%

MRVI-10.4%

Net Margin (TTM)

AZTA-20.0%

MRVI-37.1%

FCF Margin (TTM)

AZTA1.6%

MRVI-16.8%

Net Income (TTM)

AZTA$-123M

MRVI$-77M

FCF (TTM)

AZTA$10M

MRVI$-35M

EPS (TTM)

AZTA-$2.71

MRVI-$0.52

ROE (TTM)

AZTA-756.0%

MRVI-3542.0%

ROA (TTM)

AZTA-621.0%

MRVI-1054.0%

ROIC (TTM)

AZTA-756.0%

MRVI-1572.0%

Cash

AZTA$190M

MRVI$70M

Debt

AZTA$0

MRVI$177M

Net Cash/Debt

AZTA$190M

MRVI$-107M

Current Ratio (TTM)

AZTA2.50x

MRVI4.05x

Quick Ratio (TTM)

AZTA2.12x

MRVI2.63x

Debt/Equity (TTM)

AZTA0.00x

MRVI0.86x

Debt/Assets (TTM)

AZTA0.0%

MRVI0.0%

Interest Coverage (TTM)

AZTAN/A

MRVIN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

MRVI0.00x

Beta

AZTA1.51

MRVI0.63

52W Performance

AZTA17.0%

MRVI123.4%

YTD Performance

AZTA13.0%

MRVI118.8%

% from 52W High

AZTA-18.7%

MRVI-21.0%

% from 52W Low

AZTA136.8%

MRVI192.3%

Asset Turnover (TTM)

AZTA0.31x

MRVI0.28x

FCF Yield (TTM)

AZTA0.6%

MRVI-1.8%

Earnings Yield (TTM)

AZTA-7.1%

MRVI-4.0%

Dividend Yield (TTM)

AZTAN/A

MRVIN/A

Rule of 40

AZTA3.0

MRVI-20.1

EV/GP/RG

AZTA0.83

MRVI4.63

Ticker research

View AZTA research View MRVI research

Metric	AZTA Azenta Inc	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$1.74B	$1.92B
Enterprise Value	$1.55B	$2.03B
Price	$37.72	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	9.20x
EV/Sales	2.52x	9.71x
EV/EBITDA	37.55x	24.69x
P/B Ratio	1.12x	10.03x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	8.68x
Revenue & Growth
Revenue (TTM)	$614M	$209M
Revenue Growth (YoY)	1.4%	-3.3%
Forward Rev Growth	5.4%	6.5%
Profitability
Gross Margin (TTM)	43.4%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-10.4%
Net Margin (TTM)	-20.0%	-37.1%
FCF Margin (TTM)	1.6%	-16.8%
Net Income (TTM)	$-123M	$-77M
FCF (TTM)	$10M	$-35M
EPS (TTM)	-$2.71	-$0.52
ROE (TTM)	-756.0%	-3542.0%
ROA (TTM)	-621.0%	-1054.0%
ROIC (TTM)	-756.0%	-1572.0%
Financial Health
Cash	$190M	$70M
Debt	$0	$177M
Net Cash/Debt	$190M	$-107M
Current Ratio (TTM)	2.50x	4.05x
Quick Ratio (TTM)	2.12x	2.63x
Debt/Equity (TTM)	0.00x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	0.63
52W Performance	17.0%	123.4%
YTD Performance	13.0%	118.8%
% from 52W High	-18.7%	-21.0%
% from 52W Low	136.8%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.28x
FCF Yield (TTM)	0.6%	-1.8%
Earnings Yield (TTM)	-7.1%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-20.1
EV/GP/RG	0.83	4.63
Ticker research	View AZTA research	View MRVI research